ARCHIVES

QOL With Femara Comparable To Placebo, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

Funding opportunties listed.

December 3, 2004

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

Cancer Care Driven Toward: Triage” System, Puerto Rico Dean Tells AACI

July 21, 1989